{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T21:01:57Z","timestamp":1777323717360,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.intimp.2021.108490","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T12:04:14Z","timestamp":1640261054000},"page":"108490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Epigenetic drug ameliorated type 1 diabetes via decreased generation of Th1 and Th17 subsets and restoration of self-tolerance in CD4+ T cells"],"prefix":"10.1016","volume":"103","author":[{"given":"Vasu","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arathi","family":"Jayaraman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sundararajan","family":"Jayaraman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2021.108490_b0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","article-title":"Global estimates of the prevalence of diabetes for 2010 and 2030","volume":"87","author":"Shaw","year":"2010","journal-title":"Diabetes Res Clin Pract."},{"key":"10.1016\/j.intimp.2021.108490_b0010","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.immuni.2010.04.001","article-title":"Etiology of type 1 diabetes","volume":"32","author":"Todd","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2021.108490_b0015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1385\/IR:36:1:189","article-title":"Dissecting genetic control of autoimmunity in NOD congenic mice","volume":"36","author":"Ridgway","year":"2006","journal-title":"Immunol. Res."},{"key":"10.1016\/j.intimp.2021.108490_b0020","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.2337\/diabetes.52.4.1052","article-title":"Genetic liability of type 1 diabetes and the onset age among 22,650 young Finnish twin pairs: a nationwide follow-up study","volume":"52","author":"Hyttinen","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2021.108490_b0025","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrg.2016.59","article-title":"The molecular hallmarks of epigenetic control","volume":"17","author":"Allis","year":"2016","journal-title":"Nat. Rev. Genet."},{"issue":"6","key":"10.1016\/j.intimp.2021.108490_b0030","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.drudis.2015.01.007","article-title":"Histone deacetylases: structural determinants of inhibitor selectivity","volume":"20","author":"Micelli","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.intimp.2021.108490_b0035","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1073\/pnas.051507098","article-title":"Trichostatin A reverses skewed expression of CD154, interleukin-10, and interferon-gamma gene and protein expression in lupus T cells","volume":"98","author":"Mishra","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2021.108490_b0040","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2222.2004.02006.x","article-title":"Trichostatin A attenuates airway inflammation in mouse asthma model","volume":"35","author":"Choi","year":"2005","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.intimp.2021.108490_b0045","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.4049\/jimmunol.176.8.5015","article-title":"Histone hyperacetylation is associated with amelioration of experimental colitis in mice","volume":"176","author":"Glauben","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2021.108490_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2017.07.015","article-title":"The epigenetic drug Trichostatin A ameliorates experimental autoimmune encephalomyelitis via T cell tolerance induction and impaired influx of T cells into the spinal cord","volume":"108","author":"Jayaraman","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.intimp.2021.108490_b0055","first-page":"19","article-title":"Treatment of autoimmune encephalomyelitis with a histone deacetylase inhibitor. Analyzing the role of immune-response genes","volume":"1","author":"Jayaraman","year":"2020","journal-title":"Free Neuropathol."},{"key":"10.1016\/j.intimp.2021.108490_b0060","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/2211536610666210412153322","article-title":"Histone modifier differentially regulates gene expression and unravels survival role of microRNA-494 in Jurkat leukemia","volume":"10","author":"Jayaraman","year":"2021","journal-title":"Microrna."},{"key":"10.1016\/j.intimp.2021.108490_b0065","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/icb.2010.144","article-title":"Chromatin remodeling resets the immune system to protect against autoimmune diabetes in mice","volume":"89","author":"Patel","year":"2011","journal-title":"Immunol. Cell. Biol."},{"key":"10.1016\/j.intimp.2021.108490_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadva.2021.100031","article-title":"Epigenetic modulation of selected immune response genes and altered functions of T lymphocytes and macrophages collectively contribute to autoimmune diabetes protection","volume":"1","author":"Jayaraman","year":"2021","journal-title":"BBA Advances"},{"issue":"1","key":"10.1016\/j.intimp.2021.108490_b0075","doi-asserted-by":"crossref","first-page":"e55074","DOI":"10.1371\/journal.pone.0055074","article-title":"Transcriptome analysis of epigenetically modulated genome indicates signature genes in manifestation of type 1 diabetes and its prevention in NOD mice","volume":"8","author":"Jayaraman","year":"2013","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.intimp.2021.108490_b0080","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.coi.2003.09.013","article-title":"Negative selection and autoimmunity","volume":"15","author":"Ohashi","year":"2003","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.intimp.2021.108490_b0085","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/ni726","article-title":"A defect in central tolerance in NOD mice","volume":"2","author":"Kishimoto","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2021.108490_b0090","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/ni0803-717","article-title":"Efficient T cell receptor-mediated apoptosis in nonobese diabetic mouse thymocytes. author reply","volume":"4","author":"Villunger","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2021.108490_b0095","doi-asserted-by":"crossref","unstructured":"W.M. Ridgway, M. Fass\u00f2, A. Lanctot, C. Garvey, G. Fathman, G. Breaking self-tolerance in nonobese diabetic mice. J. Exp. Med. 183 (1996) 1657-1662.","DOI":"10.1084\/jem.183.4.1657"},{"issue":"4","key":"10.1016\/j.intimp.2021.108490_b0100","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1073\/pnas.95.4.1721","article-title":"Autoreactivity of T cells from nonobese diabetic mice: an I-Ag7-dependent reaction","volume":"95","author":"Kanagawa","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.intimp.2021.108490_b0105","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0065-2776(08)60402-2","article-title":"CD95(APO-1\/Fas)-mediated apoptosis: live and let die","volume":"71","author":"Krammer","year":"1999","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.intimp.2021.108490_b0110","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1034\/j.1600-065X.2003.00051.x","article-title":"Activation-induced cell death in T cells","volume":"193","author":"Green","year":"2003","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2021.108490_b0115","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0896-8411(03)00025-8","article-title":"Defect in activation-induced cell death in non-obese diabetic (NOD) T lymphocytes","volume":"20","author":"Decallonne","year":"2003","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.intimp.2021.108490_b0120","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.4049\/jimmunol.173.7.4407","article-title":"Perturbed homeostasis of peripheral T cells elicits decreased susceptibility to anti-CD3-induced apoptosis in prediabetic nonobese diabetic mice","volume":"173","author":"Yang","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2021.108490_b0125","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/MPA.0000000000000828","article-title":"Development of the nonobese diabetic mouse and contribution of animal models for understanding type 1 diabetes","volume":"46","author":"Mullen","year":"2017","journal-title":"Pancreas"},{"key":"10.1016\/j.intimp.2021.108490_b0130","first-page":"188","article-title":"Type 1 diabetes and epigenetics","volume":"Vol. 5","author":"Jayaraman","year":"2018"},{"key":"10.1016\/j.intimp.2021.108490_b0135","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2337\/diab.42.1.44","article-title":"Adoptive transfer of diabetes into immunodeficient NOD-scid\/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors","volume":"42","author":"Christianson","year":"1993","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2021.108490_b0140","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1126\/science.7761837","article-title":"T helper cell subsets in insulin-dependent diabetes","volume":"268","author":"Katz","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.intimp.2021.108490_b0145","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/eji.200838475","article-title":"Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells","volume":"39","author":"Martin-Orozco","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2021.108490_b0150","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1172\/JCI37865","article-title":"Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD\/SCID recipient mice","volume":"119","author":"Bending","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2021.108490_b0155","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.186.2.299","article-title":"T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice","volume":"186","author":"Pakala","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2021.108490_b0160","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1002\/eji.201040755","article-title":"Genetic proof for the transient nature of the Th17 phenotype","volume":"40","author":"Kurschus","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2021.108490_b0165","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2021.108490_b0170","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.2217\/bmm-2016-0091","article-title":"Chromogranin A as biomarker in diabetes","volume":"10","author":"Broedbaek","year":"2016","journal-title":"Biomark. Med."},{"key":"10.1016\/j.intimp.2021.108490_b0175","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.2337\/diabetes.53.9.2301","article-title":"Peptides from common viral and bacterial pathogens can efficiently activate diabetogenic T-cells","volume":"53","author":"Judkowski","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2021.108490_b0180","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.2353\/ajpath.2006.060539","article-title":"In CD4+ T-cell-induced diabetes, macrophages are the final effector cells that mediate islet beta-cell killing: studies from an acute model","volume":"169","author":"Calderon","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.intimp.2021.108490_b0185","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jnutbio.2009.12.001","article-title":"Increased level of exogenous zinc induces cytotoxicity and up-regulates the expression of the ZnT-1 zinc transporter gene in pancreatic cancer cells","volume":"22","author":"Jayaraman","year":"2011","journal-title":"J. Nutri. Biochem."},{"issue":"8","key":"10.1016\/j.intimp.2021.108490_b0190","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2337\/diab.47.8.1212","article-title":"Splenic macrophages from the NOD mouse are defective in the ability to present antigen","volume":"47","author":"Piganelli","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2021.108490_b0195","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2021.108490_b0200","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/ni1539","article-title":"TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology","volume":"8","author":"McGeachy","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2021.108490_b0205","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.4049\/jimmunol.181.6.3750","article-title":"Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis","volume":"181","author":"O'Connor","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2021.108490_b0210","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/eji.1830240433","article-title":"Defective T cell receptor\/CD3 complex signalling in human type I diabetes","volume":"24","author":"De Maria","year":"1994","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2021.108490_b0215","first-page":"2","article-title":"Patients with Type 1 diabetes display selective defect in antigen receptor mediated T cell apoptosis","volume":"1","author":"Jayaraman","year":"2012","journal-title":"Open J. Biol. Biochem."},{"key":"10.1016\/j.intimp.2021.108490_b0220","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1084\/jem.20071878","article-title":"Innocuous IFNgamma induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production","volume":"205","author":"Jain","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2021.108490_b0225","doi-asserted-by":"crossref","first-page":"6488","DOI":"10.4049\/jimmunol.163.12.6488","article-title":"IFN-gamma production and cytotoxicity of IL-2-activated murine NK cells are differentially regulated by MHC class I molecules","volume":"163","author":"Kubota","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2021.108490_b0230","doi-asserted-by":"crossref","first-page":"812","DOI":"10.2337\/diab.45.6.812","article-title":"Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice","volume":"45","author":"Hultgren","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2021.108490_b0235","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.2337\/diabetes.49.12.2007","article-title":"Interferon-gamma receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD mice","volume":"49","author":"Serreze","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2021.108490_b0240","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.4049\/jimmunol.170.11.5491","article-title":"IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma","volume":"170","author":"Trembleau","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2021.108490_b0245","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jaut.2011.11.017","article-title":"IFN-\u03b3 induced by IL-12 administration prevents diabetes by inhibiting pathogenic IL-17 production in NOD mice","volume":"38","author":"Zhang","year":"2012","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.intimp.2021.108490_b0250","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.2337\/db08-1113","article-title":"Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice","volume":"58","author":"Emamaullee","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2021.108490_b0255","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4049\/jimmunol.1101215","article-title":"IL-17 silencing does not protect nonobese diabetic mice from autoimmune diabetes","volume":"188","author":"Joseph","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2021.108490_b0260","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s00125-013-2935-8","article-title":"Double deficiency in IL-17 and IFN-\u03b3 signalling significantly suppresses the development of diabetes in the NOD mouse","volume":"56","author":"Kuriya","year":"2013","journal-title":"Diabetologia."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921011267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921011267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:40:36Z","timestamp":1761586836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921011267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":52,"alternative-id":["S1567576921011267"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108490","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.07.24.453657","asserted-by":"object"}]},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetic drug ameliorated type 1 diabetes via decreased generation of Th1 and Th17 subsets and restoration of self-tolerance in CD4+ T cells","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108490","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108490"}}